At this point in time, vaccines that have been authorized by WHO and/or other stringent regulatory authorities are to be used only for people from age 16 or 18, depending on the vaccine.
However, the vaccine developers have already put in place protocols for testing the vaccines in younger age groups. The results are not yet available on any of these yet.
Once the results are evaluated for safety and efficacy, WHO will be able to provide specific recommendations for particular vaccine products and younger age groups.
Vaccination is recommended for older persons without an upper age limit. Persons above the age of 85 years and very frail older persons were not included in the clinical trials. However, the data obtained in a large subset of older people with and without comorbidities suggest that the benefits of vaccination outweigh the potential risks. For very frail older persons with a life expectancy anticipated to be less than 3 months, an individual risk–benefit assessment will need to be conducted.
- Age recommendations differ per vaccine.
- 16 or 18 is the mínimum age recommended by COVID-19 vaccine producers.
- No maximum age has been recommended by producers.